{"disease":{"id":"breast-neoplasm-malignant-female","name":"breast neoplasm malignant female"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05564377","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":2900,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04475640","title":"Cancer Genetic Testing in Ethnic Populations","phase":"NA","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT02192333","title":"Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT04456140","title":"Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06938724","title":"Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":152,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT06824831","title":"Use of Microporous Polysaccharide Hemispheres in Breast Cancer Patients Undergoing Mastectomy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Fundación para la Investigación del Hospital Clínico de Valencia","has_results":false},{"nct_id":"NCT04289805","title":"Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":96,"lead_sponsor_name":"Erasme University Hospital","has_results":false},{"nct_id":"NCT05941299","title":"Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":92,"lead_sponsor_name":"Tensive SRL","has_results":false},{"nct_id":"NCT03162627","title":"Selumetinib and Olaparib in Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":90,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07162675","title":"Step Count and Treatment Response in Neoadjuvant Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":82,"lead_sponsor_name":"Ankara Etlik City Hospital","has_results":false},{"nct_id":"NCT03525990","title":"Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Dr. Vera Trommet","has_results":false},{"nct_id":"NCT04424732","title":"SBRT for Breast Cancer Oligometastases","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"King Hussein Cancer Center","has_results":false},{"nct_id":"NCT05092373","title":"Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":43,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04348955","title":"Interest of Touch-massage in Hospital Day Care","phase":"","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Institut Cancerologie de l'Ouest","has_results":false},{"nct_id":"NCT03109080","title":"Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT03435952","title":"Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":18,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05812326","title":"PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05134922","title":"Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Celcuity Inc","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}